UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Response‐guided peginterferon therapy in hepatitis B e antigen‐positive chronic hepatitis B using serum hepatitis B surface antigen levels

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.872-880

2013

Link zum Volltext

Verfügbarkeit prüfen

First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

Chinese medical journal, 2019-10, Vol.132 (19), p.2315-2324

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report

Journal of hepatology, 2011-11, Vol.55 (5), p.1121-1131

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: The lower, the better

Journal of gastroenterology and hepatology, 2010-12, Vol.25 (12), p.1812-1814

2010

Link zum Volltext

Verfügbarkeit prüfen

Current Challenges and the Management of Chronic Hepatitis C in Mainland China

Journal of clinical gastroenterology, 2014-09, Vol.48 (8), p.679-686

2014

Link zum Volltext

Verfügbarkeit prüfen

Antiviral therapy for various stages of HBV-related diseases: Lamivudine and beyond

Journal of gastroenterology and hepatology, 2008-05, Vol.23 (5), p.681-682

Jia, Ji-Dong

2008

Link zum Volltext

Verfügbarkeit prüfen

Progress in diagnosis and treatment of liver cirrhosis

Zhonghua gan zang bing za zhi, 2009-04, Vol.17 (4), p.241

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study

Journal of gastroenterology and hepatology, 2019-01, Vol.34 (1), p.12-21

2019

Link zum Volltext

Verfügbarkeit prüfen

The overview of the seminar on chronic hepatitis B

Zhonghua gan zang bing za zhi, 2004-11, Vol.12 (11), p.698

2004

Link zum Volltext

Verfügbarkeit prüfen

Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients

Zhonghua gan zang bing za zhi, 2009-12, Vol.17 (12), p.881

2009

Link zum Volltext

Verfügbarkeit prüfen

Management of HBeAg negative chronic hepatitis B

Zhonghua gan zang bing za zhi, 2005-07, Vol.13 (7), p.539

Jia, Ji-dong

2005

Link zum Volltext

Verfügbarkeit prüfen

Impact of reimbursement program on liver‐related mortality in patients with chronic hepatitis B in Beijing, China

Journal of digestive diseases, 2019-09, Vol.20 (9), p.467-475

2019

Link zum Volltext

Verfügbarkeit prüfen

Interferons for treating chronic hepatitis B

Zhonghua gan zang bing za zhi, 2007-11, Vol.15 (11), p.849

2007

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic strategies for chronic hepatitis B recommended by the American Association for the Study of Liver Diseases

Zhonghua gan zang bing za zhi, 2004-10, Vol.12 (10), p.623

2004

Link zum Volltext

Verfügbarkeit prüfen

Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48

Zhonghua shi yan he lin chuang bing du xue za ji, 2007-06, Vol.21 (2), p.102

2007

Link zum Volltext

Verfügbarkeit prüfen

The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52

Zhonghua gan zang bing za zhi, 2007-05, Vol.15 (5), p.342

2007

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a

Zhonghua gan zang bing za zhi, 2007-07, Vol.15 (7), p.481

2007

Link zum Volltext

Verfügbarkeit prüfen

A clinical study of the efficacy and safety of secretory human interferon alpha-2a treatment for chronic hepatitis B

Zhonghua gan zang bing za zhi, 2004-10, Vol.12 (10), p.589

2004

Link zum Volltext

Verfügbarkeit prüfen

The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients

Zhonghua gan zang bing za zhi, 2006-08, Vol.14 (8), p.565

2006

Link zum Volltext

Verfügbarkeit prüfen

Prevention and treatment of hepatitis B virus reinfection after liver transplantation

Chung-hua wai kʿo tsa chih, 2005-08, Vol.43 (15), p.976-979

2005

Link zum Volltext

Verfügbarkeit prüfen

Retreatment with interferon of relapsed chronic hepatitis C patients

Zhonghua gan zang bing za zhi, 2006-01, Vol.14 (1), p.3

2006

Link zum Volltext

Verfügbarkeit prüfen

Antiviral therapy for hepatitis B in special populations

Antiviral therapy, 2010-01, Vol.15 (8), p.1067-1075

2010

Link zum Volltext

Verfügbarkeit prüfen

The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C

Zhonghua gan zang bing za zhi, 2004-02, Vol.12 (2), p.72

2004

Link zum Volltext

Verfügbarkeit prüfen

Management of hepatitis C virus infection in the Asia-Pacific region: an update

The lancet. Gastroenterology & hepatology, 2017-01, Vol.2 (1), p.52-62

2017

Link zum Volltext

Verfügbarkeit prüfen

Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B

Journal of hepatology, 2022-12, Vol.77 (6), p.1515-1524

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

PublikationsformDissertationen

ThemaAntiviral Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(25)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(25)
Hepatitis B, Chronic - Drug Therapy
(13)
Male
(12)
Adult
(11)
Female
(11)
Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Middle Aged
(10)
Gastroenterology & Hepatology
(9)
Interferon-Alpha - Therapeutic Use
(9)
Lamivudine - Therapeutic Use
(7)
Treatment Outcome
(7)
Adolescent
(6)
Genotype
(6)
Young Adult
(6)
Dna, Viral - Blood
(5)
Hepatitis B E Antigens - Blood
(5)
Hepatitis B, Chronic - Virology
(5)
Polyethylene Glycols - Therapeutic Use
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response‐guided peginterferon therapy in hepatitis B e antigen‐positive chronic hepatitis B using serum hepatitis B surface antigen levels

First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

Hepatitis B surface antigen quantification: Why and how to use it in 2011 – A core group report

Hepatitis B virus DNA and hepatocellular carcinoma recurrence after resection: The lower, the better

Current Challenges and the Management of Chronic Hepatitis C in Mainland China

Antiviral therapy for various stages of HBV-related diseases: Lamivudine and beyond

Progress in diagnosis and treatment of liver cirrhosis

Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia–Pacific region and Russia: Final results from the randomized C‐CORAL study

The overview of the seminar on chronic hepatitis B

Results of 3 years of continuous entecavir treatment in nucleos(t)ide-naive chronic hepatitis B patients

Management of HBeAg negative chronic hepatitis B

Impact of reimbursement program on liver‐related mortality in patients with chronic hepatitis B in Beijing, China

Interferons for treating chronic hepatitis B

Therapeutic strategies for chronic hepatitis B recommended by the American Association for the Study of Liver Diseases

Week 24 suppression of HBV in entecavir-treated chronic hepatitis B patients in whom lamivudine treatment failed is associated with efficacy at week 48

The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52

Factors associated with HBeAg seroconversion in chronic hepatitis B patients treated with interferon alfa-2a

A clinical study of the efficacy and safety of secretory human interferon alpha-2a treatment for chronic hepatitis B

The factors associated with viral relapse after interferon treatment in chronic hepatitis C patients

Prevention and treatment of hepatitis B virus reinfection after liver transplantation

Retreatment with interferon of relapsed chronic hepatitis C patients

Antiviral therapy for hepatitis B in special populations

The influence of HCV genotype on the IFN treatment of patients with chronic hepatitis C

Management of hepatitis C virus infection in the Asia-Pacific region: an update

Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B

Aktive Filter

Suchergebnisse filtern